Aspire Biopharma Holdings, Inc. (ASBP)
0.0959
-0.01
(-8.23%)
USD |
NASDAQ |
Dec 12, 16:00
0.117
+0.02
(+22.00%)
After-Hours: 20:00
Aspire Biopharma Holdings Total Liabilities (Quarterly): 13.87M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Salarius Pharmaceuticals, Inc. | 1.849M |
| Taysha Gene Therapies, Inc. | 97.56M |
| Olema Pharmaceuticals, Inc. | 44.96M |
| Invivyd, Inc. | 46.09M |
| MSP Recovery, Inc. | 2.397B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.403M |
| Shareholders Equity (Quarterly) | -11.47M |
| Debt to Equity Ratio | -0.7521 |
| Current Ratio | 0.1734 |
| Net Debt Paydown Yield | -6.41% |